ROQAF (Roquefort Therapeutics) Other Long Term Assets : $-0.00 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Roquefort Therapeutics Other Long Term Assets?

Roquefort Therapeutics's other long-term assets for the quarter that ended in Jun. 2024 was $-0.00 Mil.

Roquefort Therapeutics's quarterly other long-term assets increased from Jun. 2023 ($-0.00 Mil) to Dec. 2023 ($0.00 Mil) but then stayed the same from Dec. 2023 ($0.00 Mil) to Jun. 2024 ($-0.00 Mil).

Roquefort Therapeutics's annual other long-term assets declined from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($-0.00 Mil) but then increased from Dec. 2022 ($-0.00 Mil) to Dec. 2023 ($0.00 Mil).

Roquefort Therapeutics Other Long Term Assets Historical Data

The historical data trend for Roquefort Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roquefort Therapeutics Other Long Term Assets Chart

Roquefort Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Other Long Term Assets

Roquefort Therapeutics Semi-Annual Data
	Jun21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Long Term Assets	Get a 7-Day Free Trial			-	-	-	-	-

Roquefort Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Roquefort Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (OTCPK:ROQAF) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

ROQ:UK

Address

85 Great Portland Street, First Floor, London, GBR, W1W 7LT

Website

https://www.roquefortplc.com

Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses. Its product portfolio consists of MDK Antibody, MDK Oligo, MDK mRNA, STAT-6 siRNA, and MK Cell. The principal activity of the Company is to develop pre-clinical next-generation medicines focused on hard-to-treat cancers.

Roquefort Therapeutics Headlines

From GuruFocus

Roquefort Therapeutics PLC at OTC Markets Life Science Investor Forum (Virtual) Transcript

By GuruFocus Research • 03-27-2024